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Purpose: Estrogen receptor alpha (ERα) expression has previously been evaluated in lens epithelial cells (LEC). However,
its function in the lens has not been determined. One potential function may be its interaction with the catalytic subunit
of telomerase (TERT), which is present in normal LEC and higher in LEC that have undergone epithelial to mesenchymal
transition (EMT). ERα is known to play a role in EMT, a process that may also involve TERT.
Methods: A commercially available transcription factor array was used to evaluate potential interactions between TERT
and other proteins in normal and cataractous LEC. Based on these findings, ERα protein and mRNA expressions were
measured using western blot analysis, immunohistochemical staining, and quantitative reverse transcription polymerase
chain reaction (RT–PCR). Co-immunoprecipitation assays were used to evaluate the interaction of TERT with ERα as
well as their phosphorylation in normal and cataractous LEC.
Results: The transcription factor array suggested that TERT interacted with ERα via the estrogen response element (ERE)
in cataractous LEC but not in normal LEC. Expression of ERα protein and mRNA increased in cataractous LEC compared
with normal LEC. Co-immunoprecipitation assays confirmed the interaction of TERT with ERα in cataractous LEC while
no interaction was found in normal LEC. LEC that have undergone EMT, e.g., cataracts, are rapidly proliferating and
migrating along the posterior lens capsule.
Conclusions: ERα is known to play a role in EMT, and our data suggests that TERT and phosphorylated protein kinase
B (pAkt) may be involved in the regulation of this process in cataractous LEC.
Estrogen receptor alpha (ERα) belongs to a superfamily
of transcription factors that mediate transcription in a ligand-
dependent  or  -independent  manner.  The  ligand-dependent
manner  requires  estrogen  while  the  ligand-independent
manner  is  by  means  of  second  messenger  signaling
mechanisms  [1,2].  Estrogen  receptors  (ER)  have  been
detected in various ocular tissues including the ciliary body,
meibomian glands, conjunctiva, lacrimal gland, and tarsal
plate as well as in human, rat, and mouse lens epithelial cells
(LEC) [3-5], though the exact role of ER in these tissues is not
known. ERα has also been recently been shown to be involved
in epithelial to mesenchymal transition (EMT) [6,7], a major
component of normal wound healing [6,8,9].
Aberrant proliferation and posterior migration of the LEC
are changes that occur in LEC during cataractogenesis and
secondary  cataract  (also  known  as  posterior  capsule
opacification [PCO]). These were previously referred to as
fibrous metaplasia or pseudometaplastic changes [10]. These
LEC have genotypic and phenotypic changes consistent with
EMT and are thought to be a wound healing response of LEC
in an attempt to repopulate the lens capsule [11-14]. Lenticular
We have previously shown that telomerase expression is
relatively low in normal LEC and increased in cataractous
LEC [20], i.e., LEC that have undergone EMT. To evaluate
telomerase  regulation  in  these  LEC,  the  present  study
compared normal and cataractous LEC using a transcription
factor array assay, which evaluated proteins interacting with
an estrogen response element (ERE). Results from this assay
led us to evaluate differences in ERα mRNA and protein
expressions  between  normal  LEC  and  LEC  that  have
undergone  EMT.  Finally,  a  probable  interaction  between
telomerase reverse transcriptase (TERT) and ERα was found
in LEC that had undergone EMT and was confirmed using co-
immunoprecipitation.  These  findings  further  our
understanding of telomerase regulation in normal LEC and
those that have undergone EMT.
METHODS
Samples:
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EMT results in the migration of the LEC onto the posterior
lens  capsule  along  with  the  production  of  aberrant
extracellular  matrix  proteins,  which  result  in  subcapsular
plaques. These changes are seen in advanced senile cataracts
as well as in inherited, congenital, diabetic, traumatic, and
ultraviolet radiation (UV)-induced cataracts and during PCO
regardless of cause or species [15-19].Normal  lens  and  anterior  lens  capsules—Normal
ocular tissues were obtained by enucleation from dogs in good
general health with normal eyes that were euthanized at a local
animal shelter for population control purposes. The animals
were humanely euthanized, and the globes were collected
within 1 h of death. Eyes were immediately placed in 2%
betadine  solution  and  then  rinsed  and  immersed  in  1×
phosphate  buffered  saline  solution  (PBS,  pH  7.2)  until
dissection, which was performed within 2 h of enucleation.
Excess conjunctiva and Tenon's capsule were excised
from the perilimbal region, and a stab incision was made into
the anterior chamber 1 mm posterior to the limbus. Anterior
lens capsules with adherent LEC were excised from each lens
for protein or RNA extraction and immediately frozen and
stored at –70 °C until extraction. Whole lenses were gently
excised from the zonular vitreal attachments and fixed in 10%
neutral buffered formalin for immunohistochemical staining.
Cataractous  anterior  lens  capsules—Anterior
capsulorhexis specimens from dogs with naturally developing
cataracts were obtained before routine phacoemulsification
cataract extraction. Naturally occurring cataracts in canine
patients are typically due to breed-related or inherited causes
or secondary to diabetes mellitus [21]. Breed-related cataracts
vary in presentation but often have diffuse cortical opacities,
and  classically,  some  breeds  will  initially  have  posterior
subcapsular or posterior cortical polar cataracts that may or
may  not  progress.  Diabetic  cataracts  in  dogs  are  rapidly
occurring and encompass the entire cortex. Canine cataract
patients  undergo  surgery  much  later  than  human  cataract
patients,  therefore,  the  cataracts  are  in  the  late  immature,
mature,  or  hypermature  stages.  These  stages  of  canine
cataracts almost universally have LEC that have undergone
EMT and posterior migration onto the posterior lens capsule
[22]. Samples chosen for this study had obvious subcapsular
plaques or diffuse LEC proliferation onto the posterior lens
capsule evident at the time of phacoemulsification. Patients
with only nuclear cataracts were not included in this study as
surgery is rarely performed on this type of cataract.
Fixed samples were obtained by continuous curvilinear
capsulorhexis and either immediately placed in 10% neutral
buffered formalin or snap frozen and stored at –70 °C until
protein or RNA extraction. Samples were paraffin embedded,
sectioned, stained with hematoxylin and eosin (H&E), and
then  examined  by  light  microscopy.  For
immunohistochemical staining, samples were sectioned onto
charged slides (ProbeOn Plus; Fisher Scientific, Pittsburgh,
PA).
Protein extraction: Whole cell protein was extracted from
frozen  normal  and  cataractous  samples  following  the
manufacturer’s  instructions  (Chemicon  International,
Temecula,  CA)  with  minor  adaptations  for  our  tissue  as
previously described [20].
Transcription  factor  array:  The  TranSignal™  TF-TF
Interaction Array I from Panomics (Fremont, CA) was used
to screen for 54 transcription factor (TF)-protein interactions.
Briefly, nuclear protein was extracted from two normal and
four  cataractous  anterior  lens  capsules.  The  normal  lens
capsule samples were approximately seven years of age. Of
the cataractous samples, two of the inherited samples and one
of  the  diabetic  samples  were  seven  years  old.  The  other
diabetic  sample  was  nine  years  of  age.  The  protein  was
quantified  by  Bradford  assay.  Each  of  the  samples  was
evaluated in two independent experiments with a negative
control (sample omitted) included each time. Each sample was
incubated  with  the  biotin-labeled,  double-stranded
oligonucleotide  probes  provided,  allowing  the  TF  cis-
elements to bind the TERT protein in the sample extracts. An
immunoprecipitation was then performed using an antibody
to TERT (Calbiochem, San Diego, CA) to pull out the TF cis-
elements interacting with TERT. Non-specific binding was
then washed away. The cis-elements were bound to TERT,
and the anti-TERT antibody were then eluted and hybridized
to  the  TranSignal  Array  membrane  (one  membrane  per
sample and a negative control; Panomics, Fremont, CA) using
the  kit’s  horse-radish  peroxidase  (HRP)-based
chemiluminescent detection system. The membranes were
spotted with 54 different TF consensus sequences, and direct
comparisons of spot intensity were made between the two
sample blots using an AlphaImager (AlphaEaseFC software,
Version 3.0; Alpha Innotech, San Leandro, CA) to identify
differences in TF-TF binding element interactions. Each blot
has positive controls incorporated along the bottom and side.
In addition, each oligonucleotide corresponding to the TF
binding  site  was  spotted  in  duplicate  and  then  again  in
duplicate at a dilution of 1:10 immediately below the full
strength TF spots. Once scanned, each of the spot pairs was
averaged, and statistical analyses were only performed on data
from ERE, MRE (mineralocorticoid response element), p53
(tumor  suppressor  gene,  p53),  and  Sp1  (transcriptional
activator  that  regulates  TERT,  the  catalytic  subunit  of
telomerase) [23]. To control for inter-experiment differences,
four blots underwent hybridization under identical conditions
each time, and then all four membranes were exposed to the
same piece of film. Each film was then scanned, and the
positive  control  spots  along  the  bottom  and  side  of  the
membrane were used to normalize the test spots. Each pair of
spots in the control rows that was directly to the right and to
the bottom of the spots being analyzed were averaged and used
to determine the value for each TF.
Immunostaining for ERα and ERβ in normal and cataractous
LEC:  Standard  avidin-biotin  complex  (ABC)
immunohistochemical staining was performed as previously
described  [22].  Primary  antibody,  anti-ERα  or  anti-ERß
(Santa  Cruz  Biotechnology  Inc.,  Santa  Cruz,  CA),  were
diluted in antibody diluent (DAKO, Carpinteria, CA) at a
dilution of 1:250. Stained samples were visualized by light
microscopy and photographed (Olympus, Melville, NY). Ten
normal and ten cataractous canine anterior lens capsules were
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used as positive controls for ERα and ERß. In addition, murine
normal  skin  and  murine  skin  with  ultraviolet-induced
squamous cell carcinoma were also used as positive controls
for ERß. The negative controls omitted the primary antibody.
Experiments were repeated three times for each sample and
antibody.
Western  blot  analysis  of  ERα:  Western  blot  analysis,
performed  as  previously  described  [24],  demonstrated  the
specificity of the anti-ERα antibody used in immunostaining
experiments and was used as a semi-quantitative method to
compare  normal  and  cataractous  anterior  lens  capsule
samples. Primary antibodies used were anti-ERα antibody
(1:1,500;  Santa  Cruz  Biotechnology  Inc)  and  anti-β-actin
antibody (1:5,000; Sigma-Aldrich, St. Louis, MO). Protein
signals were detected by chemiluminescence (Femto Western
Blotting System; Pierce Biotechnology, Rockford, IL) using
Kodak X-OMAT AR film (Eastman Kodak Co., Rochester,
NY). Membranes were stripped (Restore stripping solution;
Pierce Biotechnology), and the technique was repeated using
the anti-β-actin antibody to control for gel loading. Kodak 1D
Image Analysis Software (Kodak Molecular Imaging, New
Haven, CT) was used to obtain densitometry readings for all
western blots. Statistical analysis was performed with Prism
software (GraphPad Prism® version 4; GraphPad Software,
La Jolla, CA) using a Student t-test with Wilcoxon signed rank
test. A p value less than 0.05 was considered statistically
significant. Control samples for anti-ERα antibody included
whole protein extract from a canine mast cell tumor and a
canine mammary carcinoma, which both overexpress ERα.
Quantitative RT-PCR for ERα in normal and cataractous
LEC:  RNA  was  extracted  from  normal  and  cataractous
anterior  lens  capsule  samples  according  to  the  suggested
protocol using Absolutely RNA Microprep Kit (Stratagene,
La  Jolla,  CA).  The  ImPromII  Reverse  Transcriptase  kit
(Promega,  Madison,  WI)  was  used  to  synthesize  the  first
strand cDNA. Quantitative reverse transcription polymerase
chain reaction (RT–PCR) was performed using the Mx3000p
Multiplex Quantitation System (Stratagene) as follows: 95 °C
for 15 min, then 40 cycles at 94 °C for 30 s, 60 °C for 30 s,
and 72 °C for 30 s, using QuantiTect SYBR Green PCR kit
(Stratagene).  Primers  to  amplify  sequences  of  ERα  were
designed  based  on  previously  published  sequence  data
(GenBank AJ313195). Primers to amplify the sequence of
hypoxanthine  phosphoribosyl  transferase  (HPRT;
housekeeping control) were based on previously published
sequence  data  (NM_001003357).  Primers  employed  were
ERα/F823:  5'-GGG  GAG  GGC  AGG  AAT  GAA  GT-3′,
ERα/R934:  5′-AGG  GAC  AAG  GCT  GGG  CTG  TT-3′,
HPRT Forward: 5′-TGA CAC TGG TAA AAC AAT G-3′,
and  HPRT  Reverse:  5′-GGT  CCT  TTT  CAC  CAG  CAA
GCT-3'.
All samples were run in duplicate three separate times.
The threshold cycle value was calculated for each sample by
the instrument software (Mx3000P real-time PCR machine;
Stratagene, La Jolla, CA). The relative amount of ERα and
HPRT mRNA was calculated using the LinRegPCR software
(JM  Ruijter,  SvdVelden,  A  Ilgun,  Amsterdam,  the
Netherlands) as previously described [25]. The results were
expressed as the ratio of the target gene, ERα, to the HPRT
housekeeping gene. Statistical analysis was performed with
Prism software (GraphPad Prism® version 4) using a Student
t-test with Wilcoxon signed rank test. A p value less than 0.05
was considered statistically significant.
Immunoprecipitation and immunoblotting of ERα and TERT:
A total of eight normal and 18 cataractous canine anterior lens
capsule  samples  were  evaluated.  Two  kits  were  used  to
perform this experiment separately to ensure results were
consistent.  The  Seize  Classic  Mammalian
Immunoprecipitation  kit  and  the  Seize  Mammalian
Immunoprecipitation  Plate-based  kit  (both  from  Pierce
Biotechnology)  were  used  following  the  manufacturer’s
instructions. Briefly, the initial step coupled the appropriate
affinity  purified  antibody  (anti-ERα  antibody;  Santa  Cruz
Biotechnology  Inc.)  to  the  AminoLink  Plus  Coupling  gel
(ThermoFisher  Scientific  Inc.,  Rockford,  IL).  Five
micrograms  of  protein  were  immunoprecipitated  to  the
antibody coupled gel. Similar to the Classic kit, the plate-
based kit’s initial step bound the capture antibody (anti-ERα;
Santa Cruz Biotechnology Inc.) to the protein G coated wells.
Protein samples (10 µg) were then immunoprecipitated, and
following  appropriate  incubation  and  washes,  the
antigen:antibody complex was eluted. Controls for the plate-
based  Seize  kit  included  a  well  without  either  antigen  or
antibody. Elutions from both kits were applied to a SDS–
PAGE gel for electrophoresis and immunoblotting with anti-
TERT antibody (TERT L-20; Santa Cruz Biotechnology Inc.).
To  ensure  that  results  were  consistent,  the  opposite  was
performed,  i.e.,  capture  with  anti-TERT  antibody  and
immunoblot with anti-ERα antibody. All experiments were
performed in duplicate and repeated as well.
Phosphorylation  of  ERα  and  TERT:  Phosphorylation
evaluation  was  performed  using  the  Omni-Phos®
Phosphorylation  Assay  Kit  (Chemicon  International,  Inc,
Temecula, CA) according to the manufacturer’s instructions.
A  co-immunoprecipitation  approach  using  The  Seize®
Mammalian  Immunoprecipitation  Plate-based  kit  (Pierce
Biotechnology) was used wherein either anti-ERα antibody
(Santa Cruz Biotechnology Inc.) or anti-TERT was used to
capture the protein present in each sample. Samples included
normal canine anterior lens capsules (n=2), diabetic canine
cataract  samples  (n=2),  and  breed-related  canine  cataract
samples  (n=2).  Data  shown  is  representative  of  both
experiments. The captured protein was eluted, subjected to
SDS–PAGE,  and  immunoblotted  with  the  Omni-Phos®
Blend, which includes phosphothreonine, phosphoserine, or
phosphotyrosine antibodies according to the manufacturer’s
directions. Blots were then stripped, and immunoblotting was
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Technology®,  Danvers,  MA)  under  similar  conditions
described for western blot analysis. Secondary antibody used
was donkey anti-mouse (1:8,000; Santa Cruz Biotechnology
Inc.).
RESULTS
Transcription factor array: TFs that interacted with TERT in
normal and cataractous LEC are shown in Figure 1. Four of
these  are  highlighted  in  Figure  1  to  demonstrate  signal
intensity differences. These are ERE, p53, Sp1, and MRE.
Immunohistochemical staining for ERα and ERß in normal
and cataractous LEC: Immunostaining for ERα was very
strong in the nuclei and cytoplasm of naturally occurring
cataractous canine LEC and minimal in normal canine LEC
(Figure  2A).  In  addition,  cataractous  LEC  demonstrate
extracellular  matrix  production  seen  in  areas  where  the
capsule appears to be in between and above the LEC (Figure
2B).  None  of  the  cells  in  any  sample  showed  positive
immunoreactivity for ERß.
Western blot analysis of ERα: Western blot analysis with anti-
ERα antibody was performed on normal canine LEC from
freshly harvested lenses (n=6), anterior capsulotomy samples
from canine patients undergoing routine cataract extraction
(n=10),  and  canine  tumor  controls  (mast  cell  tumor  and
mammary  adenocarcinoma).  Expression  was  present  but
minimal in the normal LEC when compared to the cataract
samples, which showed increased expression of ERα (Figure
2E).
Quantitative RT-PCR for ERα in normal and cataractous
LEC: Normal canine LEC (n=6) had significantly (p=0.0423)
lower expression of ERα mRNA than canine cataractous LEC
(n=16;  Figure  3).  Expression  of  ERα  relative  to  HPRT
expression was approximately two times higher in cataractous
LEC.
Immunoprecipitation  of  ERα  and  TERT:  Co-
immunoprecipitation  showed  that  ERα  is  interacting  with
TERT in cataractous LEC. However, there was no interaction
between ERα and TERT seen in normal LEC (Figure 4).
Phosphorylation  of  ERα  and  TERT:  Immunoprecipitation
with either anti-ERα (ER) or TERT (T) antibodies followed
by  immunoblotting  with  either  Omni-Phos®  or  anti-pAkt
antibodies  was  performed  (Figure  5).  Preliminary
phosphorylation  evaluation  using  the  Omni-Phos®
Phosphorylation Assay Kit identified that ERα and TERT in
both diabetic and breed-related cataract samples have more
phosphorylation than normal samples. This method also elutes
the  initial  antibody.  Therefore,  the  graph  in  Figure  5B
demonstrates net intensity of each band, that is, the intensity
of  the  control  (C,  antibody  alone)  subtracted  from  the
intensities of each band. The graph in Figure 5C demonstrates
the fold difference from the control, giving the control a value
of 1 and then dividing the intensity signal of each band by the
control value.
Since pAkt has been shown to phosphorylate both ERα
and TERT, we then performed immunoprecipitation of ERα
or TERT with normal and cataractous LEC lysates followed
by immunoblotting with the anti-pAkt antibody. The results
Figure  1.  Transcription  factor  array  comparing  normal  and
cataractous  LEC.  A-C:  The  TransSignal™  (Panomics)  TF-TF
interaction array using one normal and two cataractous canine LEC
samples. Nuclear extract was mixed with the TransSignal Probe mix,
and immunoprecipitation was performed using a polyclonal antibody
to TERT (Calbiochem, San Diego, CA). A: Normal sample from an
approximately seven- to nine-year-old dog. B: Diabetic cataract from
an  approximately  seven-  to  nine-year-old  dog.  C:  Breed-related
cataract from an approximately seven- to nine-year-old dog. Each
TF is spotted on the blot in duplicate at the same concentration and
then directly below those two spots at a 1:10 dilution in duplicate.
Four of the TFs are boxed to show signal intensity differences: ERE
(1), p53 (2), Sp1 (3), and MRE (4). It is evident that the normal
sample shows less spot intensity of these TFs when compared to the
cataract samples. D: Graph depiction of the four TFs boxed in A-C
demonstrating interaction of TERT with ERE, p53, Sp1, and MRE.
The cataractous samples had higher signal intensity than the normal
samples. The normal samples showed some interaction of TERT with
ERE, Sp1, and MRE. However, there was no p53 interaction with
TERT. The blots shown are representative of repeated experiments.
Error bars indicate standard error of the mean (SEM).
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proteins in cataractous LEC but not in normal LEC (Figure
5D-F). These findings strongly suggest that phosphorylation
of  TERT  and  ERα  may  be  Akt-dependent  [26]  during
cataractogenesis and that pAkt is not the kinase involved in
normal LEC-telomerase activity.
DISCUSSION
We  previously  reported  that  telomerase  activity  and  its
components had a low level of expression in normal canine
LEC and significantly increased expression in cataractous
LEC [20,27]. TERT is the catalytic subunit of telomerase, and
TR is the RNA subunit of telomerase. While TR is expressed
at a basal level in all cells, TERT is only expressed in cells
that have telomerase activity. Therefore, it is well accepted
Figure 2. Protein expression of ERα in normal and cataractous LEC.
Representative results are shown of immunohistochemical staining
with anti-ERα antibody in normal canine LEC (A) and anterior
capsulotomy samples from canine patients with naturally occurring
cataract (B). B shows more extracellular matrix surrounding many
of the cells, which is typical of LEC that have undergone EMT and
make aberrant collagens. Both the nuclei (large arrowheads) and the
cytoplasm are immunopositive in the cataractous sample whereas the
normal sample has less intense immunostaining in both. Extracellular
matrix production is seen in between and above the cataractous LEC
(red arrows). Immunostaining results are representative of repeated
(three times) experiments. Chromogen is DAB with hematoxylin
counterstain.  Magnification,  400×.  C:  Canine  mammary
adenocarcinoma shows nuclear and cytoplasmic immunopositivity
in the acini and in some of the surrounding stromal cells. D: Canine
mammary  adenocarcinoma  served  as  a  negative  control  and  is
representative of all negative control slides used. E: Western blot
analysis compares the expression of ERα in normal LEC (three
different  age  groups)  and  naturally  occurring  breed-related/
presumed-inherited cataractous LEC samples. Normal LEC express
ERα less than the cataractous LEC. N=normal canine lens. Controls
include canine tumor samples overexpressing ERα (MCT=mast cell
tumor, Mel=melanoma).
that  TERT  expression  correlates  with  telomerase  activity
[28-31]. TERT is known to function in proliferation and in
DNA repair, depending on its location within the cell [32],
and  it  is  regulated  on  all  levels,  i.e.,  transcriptionally,
translationally,  and  posttranslationally  [33-36].  To  find
potential candidate proteins involved in interacting with and
regulating TERT in LEC, a transcription factor array was
used. We found numerous transcription factors with which
TERT was interacting and chose to further investigate the
ERE  and  its  binding  proteins,  ERα  and  ERß.
Immunohistochemical analysis revealed that ERß protein was
not detectable in normal or cataractous canine LEC and, as
Figure 3. Quantitative RT–PCR for ERα in canine LEC. Data are
shown as the gene of interest (ERα) divided by the housekeeping
gene  (HPRT).  Cataractous  LEC  had  significantly  higher  ERα
expression than normal LEC. The asterisk indicates p=0.0423.
Figure 4. Immunoprecipitation of ERα followed by western blot
analysis  using  anti-TERT  antibody.  Lane  1  is  a  non-
immunoprecipitated protein sample from normal LEC expressing
minimal ERα. Lane 2 shows lack of interaction between ERα and
TERT in normal canine LEC. Lane 3 is a non-immunoprecipitated
protein sample from cataractous LEC expressing more ERα than
normal LEC in Lane 1. Lane 4 demonstrates interaction between
ERα  and  TERT  in  cataractous  LEC.  This  experiment  is
representative of two repeated experiments and was performed in
reverse twice as well with similar results.
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regulate TERT in human ovarian and prostatic cells [26,37,
38]. The goal of this study was to determine the expression of
ERα in normal and cataractous LEC as well as verify the
interaction between ERα and TERT in cataractous LEC. We
discovered that there were increased ERα protein and mRNA
expressions in cataractous LEC when compared to normal
LEC  and  that  ERα  and  TERT  consistently  interacted  in
cataractous  LEC.  We  did  not  investigate  whether  the
interaction was direct or indirect.
ERα belongs to a superfamily of transcription factors that
mediates  transcription  in  a  ligand-dependent  or  a  ligand-
independent manner. The ligand-dependent manner requires
estrogen, and the ligand-independent manner is by means of
second messenger signaling mechanisms such as Akt [1,2].
Typically in the absence of estrogen, ERα is complexed with
heat shock protein 90 (hsp90), which prevents interaction
between  ERα  and  the  transcription  apparatus  [39].  Upon
Figure 5. Immunoprecipitation of TERT or ERα from normal and
cataractous  LEC  lysates  followed  by  immunoblotting  with  anti-
Omni-Phos antibody or anti-pAkt antibody. A-C: Anti-Omni-phos®
antibody detected nonspecific phosphorylation of ERα and TERT in
both normal and cataractous LEC, though the immunoprecipitated
TERT  and  ERα  proteins  were  shown  to  be  more  highly
phosphorylated in cataractous than in normal LEC. D-F: Anti-pAkt
antibody revealed that pAkt interacts with ERα and TERT proteins
in cataractous LEC but not in normal LEC. These findings imply that
phosphorylation  of  TERT  and  ERα  is  Akt-dependent  during
cataractogenesis and that pAkt is not the kinase involved in normal
LEC-telomerase  activity.  C=control;  n=normal  LEC;  D  and
I=naturally occurring (diabetic or inherited) canine cataractous LEC;
ER or ERα=estrogen receptor alpha; T=TERT. This experiment is
representative of two repeated experiments. Statistical analysis was
not performed.
activation,  ERα  is  able  to  bind  estrogen  and  the  receptor
undergoes a conformational change that permits binding with
co-activators allowing initiation of target gene transcription.
We have shown that hsp90 expression is negligible in normal
and cataractous LEC, and there is no detectable interaction of
hsp90 with ERα or TERT in either normal or cataractous LEC
[20]. Therefore, either this interaction is not necessary for
ERα to drive downstream regulation or a different co-activator
is used by ERα in LEC. It is also possible that so little hsp90
is  expressed  that  an  interaction  is  not  detectable  by  our
methods.
ERα has been shown to be present in the rat and human
LEC  [40-43],  and  we  now  demonstrate  its  expression  in
canine LEC. We detected low but detectable levels of ERα
mRNA  and  protein  in  normal  canine  LEC  and  increased
expression in LEC from canine cataracts. We are presently
determining whether this increased expression of ERα is a
cause or effect of EMT. A recent report in a breast cancer cell
line suggests that there is cross talk among ERα, snail, and the
TGF-ß signaling pathway in EMT [44]. All of these proteins
have been found in the lens and therefore may be involved in
lens EMT. EMT is suggested to be a wound healing response
of the LEC to replace abnormal or degenerate LEC [45] and
is a feature of LEC in cataracts and in secondary cataract
formation (aka posterior capsule opacification, PCO, after-
cataract) [46-51]. Cataracts included in this study were late
immature,  mature,  or  hypermature  cortical  cataracts.  No
nuclear or senile cataracts were included in any experiments.
Cortical cataracts in dogs are characterized even at immature
stages with EMT of the anterior LEC, resulting in posterior
migration of the LEC, subcapsular plaque formation with
multiple  layering  of  LEC,  and  production  of  aberrant
extracellular matrix proteins [22]. In addition, we have found
that canine cataract patients develop PCO in 100% of cases
when  using  intraocular  lens  prostheses  that  do  not  have
squared edges [52].
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ERα mRNA and protein have been found in a variety of
ocular cell types in both humans and monkeys [3-5,54-56]. In
human  retinal  pigmented  epithelium  of  both  males  and
females,  ERα  mRNA  and  protein  expressions  have  been
shown to be regulated in an estrogen-dependent manner [57].
Another  study  using  human  eyes  found  that  ERα  mRNA
expression was detected in the retina and retinal pigment
epithelium  (RPE)  of  young  females  but  not  in  males  or
postmenopausal women. The same study detected ERα in the
nonpigmented ciliary epithelium, the iris, and the LEC [43].
Most recently, Cammarata et al. [58] identified ERα in human
LEC, suggesting a role for estrogen in lens physiology. As a
transcription factor, ERα may be performing a variety of roles
in the eye since so many ocular cell types express this protein.
Whether estrogen is important in all of these cells has not been
evaluated. We are presently attempting to characterize the
various aspects of estrogen biosynthesis in LEC in hopes toelucidate why estrogen seems to protect LEC from cataract
and whether ERα plays a role in this phenomenon.
Female transgenic mice expressing a dominant negative
ERα (i.e., ERα is not able to bind estrogen) develop cortical
cataracts, which begin in the equatorial region after puberty
and  progress  with  age  [59].  These  LEC  however  do  not
undergo phenotypic changes consistent with EMT or migrate
across the posterior capsule (personal communication with
Dr. Vicki Davis and evaluation of Dr. Davis’ histological
slides  by  the  authors).  This  suggests  that  fully  functional
ERα is important for the EMT that can occur during cataract
formation [59]. Although, it is also possible that we have
evaluated these lenses too early, i.e., before the LEC undergo
EMT.
Estrogen has been shown to enhance ERα and TERT
phosphorylation [2,26]. The phosphorylation of ERα results
in various functions including DNA binding, recruitment of
co-activators, and transcriptional activation [2]. ERα and its
co-activators can bind target promoters at the palindromic
ERE(s) to stimulate transcription. There are two EREs present
on the human TERT promoter (localized in 1 kb of the 5′
flanking region) [37], and two EREs are present on the canine
TERT promoter region (GenBank AY833719). Consistent
with the transcription factor array, this would support the
interaction between ERα and TERT, possibly influenced by
estrogen.  Unfortunately,  we  have  been  unable  to  culture
cataractous canine LEC (i.e., those that have undergone EMT)
to evaluate whether ERα is phosphorylated by estrogen in
these cells. However, we are in the process of overexpressing
ERα in primary cultures of normal LEC in an attempt to
evaluate this mechanism.
We  were  able  to  preliminarily  evaluate  the
phosphorylation  status  of  both  ERα  and  TERT  via  co-
immunoprecipitation  experiments.  Using  the  nonspecific
phosphorylation antibodies, we were able to demonstrate that
both proteins are phosphorylated in normal and cataractous
LEC. Since cataractous LEC have a higher expression of both
proteins, it was not surprising that the cataractous LEC had a
higher co-expression of the nonspecific kinase mix. Since
both proteins are phosphorylated by pAkt in other cell types
[60,61], and we had previously found pAkt to have a higher
expression in cataractous LEC [62], we chose to include pAkt
in these experiments. This is the first study demonstrating that
Akt phosphorylates both ERα and TERT in cataractous LEC.
Further  work  is  required  to  identify  the  kinase  that
phosphorylates ERα and TERT in normal LEC.
In  summary,  we  have  shown  that  ERα  has  very  low
expression in normal canine LEC and increased expression in
cataractous LEC, i.e., LEC that have undergone EMT. While
we currently do not know the temporal or causal relationship
between ERα expression and the process of EMT, we are
presently investigating this in our laboratory. In addition, we
have determined that TERT, which is also overexpressed in
cataractous  LEC,  is  interacting  with  ERα,  and  both  are
phosphorylated by pAkt in cataractous LEC (LEC that have
undergone EMT). The role of estrogen in this interaction is
unknown. However, we hope that these findings will lead to
understanding how estrogen seems to protect LEC against
cataractogenesis.
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